BTK-IN-15
Product Specifications
Target
Others|||Pyroptosis|||BTK
Related Pathways
Immunology/Inflammation|||Others|||Angiogenesis|||Tyrosine Kinase/Adaptors|||Apoptosis
Bioactivity
BTK-IN-15 is a novel, orally active Bruton's tyrosine kinase (BTK) inhibitor that inhibits BTK (IC50: 0.7 nM) . BTK-IN-15 induces apoptosis in cancer cells and has good kinase selectivity and anti-tumour activity.
Molecular Formula
C28H24FN5O2
Molecular Weight
481.52
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15163872 1 Vial
Lentiviral human SDAD1 shRNA (UAS) - Lentiviral human SDAD1 shRNA (UAS, RFP) (100)
Ask
View Details